4R9Y image
Deposition Date 2014-09-08
Release Date 2015-12-16
Last Version Date 2024-11-20
Entry Detail
PDB ID:
4R9Y
Title:
Crystal structure of KKOFab in complex with platelet factor 4
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
4.11 Å
R-Value Free:
0.38
R-Value Work:
0.31
R-Value Observed:
0.31
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Platelet factor 4
Gene (Uniprot):PF4
Chain IDs:A (auth: D), B (auth: C), E (auth: B), F (auth: A)
Chain Length:70
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Platelet factor 4 antibody KKO heavy chain
Chain IDs:D (auth: H), H (auth: N)
Chain Length:218
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Platelet factor 4 antibody KKO light chain
Chain IDs:C (auth: L), G (auth: M)
Chain Length:214
Number of Molecules:2
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
Nat Commun 6 8277 8277 (2015)
PMID: 26391892 DOI: 10.1038/ncomms9277

Abstact

Heparin-induced thrombocytopenia (HIT) is an autoimmune thrombotic disorder caused by immune complexes containing platelet factor 4 (PF4), antibodies to PF4 and heparin or cellular glycosaminoglycans (GAGs). Here we solve the crystal structures of the: (1) PF4 tetramer/fondaparinux complex, (2) PF4 tetramer/KKO-Fab complex (a murine monoclonal HIT-like antibody) and (3) PF4 monomer/RTO-Fab complex (a non-HIT anti-PF4 monoclonal antibody). Fondaparinux binds to the 'closed' end of the PF4 tetramer and stabilizes its conformation. This interaction in turn stabilizes the epitope for KKO on the 'open' end of the tetramer. Fondaparinux and KKO thereby collaborate to 'stabilize' the ternary pathogenic immune complex. Binding of RTO to PF4 monomers prevents PF4 tetramerization and inhibits KKO and human HIT IgG-induced platelet activation and platelet aggregation in vitro, and thrombus progression in vivo. The atomic structures provide a basis to develop new diagnostics and non-anticoagulant therapeutics for HIT.

Legend

Protein

Chemical

Disease

Primary Citation of related structures